Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4086.0
(-0.61%)
JPY 4086.0
(-0.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 13.16 Billion JPY | 13.53% |
| 2022 | 11.59 Billion JPY | 24.23% |
| 2021 | 9.33 Billion JPY | -12.5% |
| 2020 | 10.67 Billion JPY | -53.05% |
| 2019 | 22.72 Billion JPY | 2.02% |
| 2018 | 22.27 Billion JPY | -15.44% |
| 2017 | 26.34 Billion JPY | 0.15% |
| 2016 | 26.3 Billion JPY | -5.14% |
| 2015 | 27.73 Billion JPY | 35.09% |
| 2014 | 20.52 Billion JPY | 7.34% |
| 2013 | 19.12 Billion JPY | -24.49% |
| 2012 | 25.32 Billion JPY | -2.36% |
| 2011 | 25.93 Billion JPY | -8.0% |
| 2010 | 28.19 Billion JPY | -1.37% |
| 2009 | 28.58 Billion JPY | -12.13% |
| 2008 | 32.53 Billion JPY | 11.91% |
| 2007 | 29.07 Billion JPY | 11.24% |
| 2006 | 26.13 Billion JPY | 14.77% |
| 2005 | 22.77 Billion JPY | 5.93% |
| 2004 | 21.49 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 4.85 Billion JPY | 17.04% |
| 2024 Q1 | 4.15 Billion JPY | 362.14% |
| 2023 Q1 | 4.36 Billion JPY | 41.0% |
| 2023 Q2 | 4.03 Billion JPY | -7.48% |
| 2023 Q4 | 898 Million JPY | -76.82% |
| 2023 FY | 13.16 Billion JPY | 13.53% |
| 2023 Q3 | 3.87 Billion JPY | -3.99% |
| 2022 Q1 | 519 Million JPY | -78.05% |
| 2022 FY | 11.59 Billion JPY | 24.23% |
| 2022 Q2 | 4.39 Billion JPY | 746.63% |
| 2022 Q4 | 3.09 Billion JPY | -13.92% |
| 2022 Q3 | 3.59 Billion JPY | -18.23% |
| 2021 Q4 | 2.36 Billion JPY | 86.58% |
| 2021 Q1 | 2.12 Billion JPY | -16.8% |
| 2021 Q2 | 3.58 Billion JPY | 69.15% |
| 2021 FY | 9.33 Billion JPY | -12.5% |
| 2021 Q3 | 1.26 Billion JPY | -64.67% |
| 2020 Q3 | 2.6 Billion JPY | -41.26% |
| 2020 FY | 10.67 Billion JPY | -53.05% |
| 2020 Q1 | 1.07 Billion JPY | -74.99% |
| 2020 Q2 | 4.43 Billion JPY | 311.69% |
| 2020 Q4 | 2.54 Billion JPY | -2.26% |
| 2019 Q3 | 8.22 Billion JPY | 11.0% |
| 2019 FY | 22.72 Billion JPY | 2.02% |
| 2019 Q1 | 2.77 Billion JPY | -56.16% |
| 2019 Q2 | 7.41 Billion JPY | 166.81% |
| 2019 Q4 | 4.31 Billion JPY | -47.61% |
| 2018 Q3 | 4.71 Billion JPY | -31.46% |
| 2018 FY | 22.27 Billion JPY | -15.44% |
| 2018 Q1 | 4.35 Billion JPY | -23.05% |
| 2018 Q4 | 6.33 Billion JPY | 34.49% |
| 2018 Q2 | 6.87 Billion JPY | 57.9% |
| 2017 Q2 | 7.53 Billion JPY | 48.11% |
| 2017 Q1 | 5.09 Billion JPY | 18.07% |
| 2017 FY | 26.34 Billion JPY | 0.15% |
| 2017 Q4 | 5.65 Billion JPY | -29.78% |
| 2017 Q3 | 8.05 Billion JPY | 6.88% |
| 2016 Q1 | 5.74 Billion JPY | 30.37% |
| 2016 Q4 | 4.31 Billion JPY | -52.73% |
| 2016 FY | 26.3 Billion JPY | -5.14% |
| 2016 Q3 | 9.12 Billion JPY | 27.89% |
| 2016 Q2 | 7.13 Billion JPY | 24.15% |
| 2015 Q2 | 8.77 Billion JPY | 52.9% |
| 2015 Q4 | 4.4 Billion JPY | -50.02% |
| 2015 Q3 | 8.81 Billion JPY | 0.49% |
| 2015 FY | 27.73 Billion JPY | 35.09% |
| 2015 Q1 | 5.73 Billion JPY | 17.32% |
| 2014 FY | 20.52 Billion JPY | 7.34% |
| 2014 Q4 | 4.89 Billion JPY | -7.42% |
| 2014 Q3 | 5.28 Billion JPY | -8.38% |
| 2014 Q2 | 5.76 Billion JPY | 25.6% |
| 2014 Q1 | 4.59 Billion JPY | 621.7% |
| 2013 Q3 | 6.02 Billion JPY | -18.48% |
| 2013 Q4 | 636 Million JPY | -89.44% |
| 2013 FY | 19.12 Billion JPY | -24.49% |
| 2013 Q1 | 5.07 Billion JPY | 11.38% |
| 2013 Q2 | 7.39 Billion JPY | 45.75% |
| 2012 Q3 | 7.52 Billion JPY | -5.17% |
| 2012 Q2 | 7.93 Billion JPY | 49.35% |
| 2012 FY | 25.32 Billion JPY | -2.36% |
| 2012 Q4 | 4.55 Billion JPY | -39.5% |
| 2012 Q1 | 5.31 Billion JPY | 3.97% |
| 2011 Q2 | 6.41 Billion JPY | -5.69% |
| 2011 Q3 | 7.61 Billion JPY | 18.71% |
| 2011 Q4 | 5.11 Billion JPY | -32.88% |
| 2011 FY | 25.93 Billion JPY | -8.0% |
| 2011 Q1 | 6.8 Billion JPY | 16.18% |
| 2010 Q2 | 9.08 Billion JPY | 35.98% |
| 2010 Q1 | 6.68 Billion JPY | 86.91% |
| 2010 Q4 | 5.85 Billion JPY | -10.93% |
| 2010 FY | 28.19 Billion JPY | -1.37% |
| 2010 Q3 | 6.57 Billion JPY | -27.68% |
| 2009 Q2 | 8.43 Billion JPY | 17.98% |
| 2009 Q1 | 7.15 Billion JPY | 0.0% |
| 2009 FY | 28.58 Billion JPY | -12.13% |
| 2009 Q4 | 3.57 Billion JPY | -62.04% |
| 2009 Q3 | 9.41 Billion JPY | 11.63% |
| 2008 FY | 32.53 Billion JPY | 11.91% |
| 2007 FY | 29.07 Billion JPY | 11.24% |
| 2006 FY | 26.13 Billion JPY | 14.77% |
| 2005 FY | 22.77 Billion JPY | 5.93% |
| 2004 FY | 21.49 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -157.52% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 93.849% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 103.717% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 92.321% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 6834.659% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 58.048% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -38.411% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 75.346% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -1738.966% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -126.9% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -570.418% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 2765.385% |
| Tsumura & Co. | 20.01 Billion JPY | 34.224% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -227.782% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -161.458% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 25.391% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -241.291% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -35.51% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -118.976% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 527.639% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -238.136% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 1722.215% |
| MedRx Co., Ltd | -933 Million JPY | 1511.254% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -155.571% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 1256.014% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 655.57% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -102.569% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 30.282% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 1987.912% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 31.887% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -200.458% |